Abstract:The ligand 2-['2-(4,5-dimethyl thiazolyl)azo]-imidazole (DMeTAI), which is generated from 2-amino-4,5-dimethylthiazol and imidazole, was used to synthesize coordination compounds containing Ni(II) and Cu(II) ions. To confirm the structure of the synthesized chelates, a range of analytical techniques were used, including thermal analysis, X-ray powder diffraction, infrared spectroscopy, mass spectrometry, magnetic susceptibility analysis, microanalysis, and 1 H NMR. The complexes have the formula [M(L) 2 ]Cl 2 .H 2 O, where M stands for Ni(II) or Cu(II), and the results showed that the metal ion–ligand ratio was 1:2. Molar conductivity results demonstrated that the complexes are all electrolytes that fall within a certain range 77.01–83.56 Ω −1 cm 2 mol −1 , and the magnetic susceptibility measurements indicated an octahedral structural geometry for the complexes. Besides, the central metal ion interacts with the ligand as a tridentate (N,N,N) coordination by the (C=N) nitrogen atom from the thiazole moiety, the (N=N) nitrogen atom from the azo group, and the (C=N) nitrogen atom from the imidazole moiety. Thermal analysis (TG/DTG) showed that the thermal decomposition of the obtained compounds is a multi-stage process depending on the metal ion and atmosphere in which was conducted. Computational methods were subsequently utilized to delve more deeply into the properties of both the ligand and metallic complexes. The structural formulas of the examined azo dye ligand and metal complexes were optimized using the Gaussian09 program. Additionally, the DFT/B3LYP method was employed to compute energy gaps and other pertinent theoretical parameters. Molecular docking using the MOE 2015 program was utilized to explore the interactions of the compounds with the human p110alpha/p85alpha complex (PDB ID: 2RD0), which is associated with ovarian carcinoma. We determined the energies of hydrophobic and hydrogen bonding from the analysis of the docked protein receptors. In addition to the theoretical investigations, both the ligand and metallic complexes were evaluated for their effectiveness as antibacterial agents against Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and the antifungal strain Penicillium sp. The findings revealed that the ligand and its metallic complexes demonstrated moderate antimicrobial efficacy against both Gram-positive and Gram-negative microbes, surpassing the standard drugs Ciprofloxacin and Cycloheximide. Additionally, the cytotoxicity of the ligand was assessed against human ovarian carcinoma cancer cells (SKOV-3). Furthermore, in silico ADMET analysis predicted favourable pharmacokinetic and toxicity profiles for the synthesized molecules, indicating promising oral drug-like properties and a nontoxic nature.

Synthesis of steroidal 1,2- and 1,3-diamines as ligands for transition metal ion complexation

Synthesis of New Cisplatin Derivatives from Bile Acids

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Designing metal chelates of halogenated sulfonamide Schiff bases as potent nonplatinum anticancer drugs using spectroscopic, molecular docking and biological studies

Synthesis and antiproliferative activity of cisplatin‐3‐chloropiperidine conjugates

Synthesis, Characterization, Biological, ADMET, and Molecular Docking Studies of Transition Metal Complexes of Aminopyridine Schiff Base Derivative

Synthesis, Structural, DFT, In Vitro Biological Exploration, and DNA Interaction of New Ni(II) and Cu(II) Mixed‐Ligand Complexes Featuring 2,2′‐Pyridine‐2,6‐diylbis(1H‐benzimidazole) and 2‐Hydroxy‐naphthaldehyde‐Based Schiff‐Base

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Synthesis and Cytotoxic Evaluation of Novel Platinum(Ii) Complexes with C2-Asymmetric and C2-Symmetric Chiral Vicinal Diamines

Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: Synthesis, solution speciation, interaction with biomolecules and anticancer activity

Synthesis, and characterization of Ni(II), and Cu(II) metal complexes containing new azo dye ligand (N,N,N) and evaluation of their biological activities supported by DFT studies, molecular docking, ADMET profiling, drug-likeness analysis and toxicity prediction

Synthesis, characterization, biological potency, and molecular docking of Co2+, Ni2+ and Cu2+ complexes of a benzoyl isothiocyanate based ligand

Triazole-based Mn(II), Fe(II), Ni(II), Cu(II) and Zn(II) complexes as potential anticancer agents – Physicochemical properties, in silico predictions and in vitro activity

Design and Synthesis of Diphosphine Ligands Based on the Chiral Biindolyl Scaffold and Their Application in Transition-Metal Catalysis

Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates

Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance

Chemoenzymatic synthesis of C14-functionalized steroids

Synthesis and Characterization Some Transition Metal Complexes of New Ligand Chalcone-Azo Derivatives from P-methoxy-4, 5-diphenyl Imidazole and Study Biological Effect of Pd(II) Complex

Glucoconjugated Dinuclear Copper(II) Complex: An Efficient Catalyst for Stereoselective Synthesis of Trisubstituted Propargylamines via Solvent‐free A3 Coupling Reaction

Diamidophosphites from β-hydroxyamides: readily assembled ligands for Pd-catalyzed asymmetric allylic substitution